ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2012
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Implications for Management of PET Amyloid Classification Technology
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study - A Study to Improve Precision in Amyloid PET Coverage and Patient Care
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Attitudes and preferences towards screening for dementia: a systematic review of the literature.BMC geriatrics · 2015Pooled it
- Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.The journal of nutrition, health & aging · 2015Pooled it
- Tasks and Activities of an Effective Collaborative Dementia Care Management Program in German Primary Care.Journal of Alzheimer's disease : JAD · 2022Trial
- Dementia care management: going new ways in ambulant dementia care within a GP-based randomized controlled intervention trial.International psychogeriatrics · 2014Trial
- NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.International journal of molecular sciences · 2021Article
- Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.Neuroscience bulletin · 2021Review
- Evaluation of Nootropic Activity ofTurkish journal of pharmaceutical sciences · 2021Article
- Article
- Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.Journal of Alzheimer's disease : JAD · 2020Review
- The value of the GP's clinical judgement in predicting dementia: a multicentre prospective cohort study among patients in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2019Article
- Article
- Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.Journal of the American Medical Directors Association · 2018Article
- Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.Bioinformation · 2018Article
- An Education Intervention to Enhance Staff Self-Efficacy to Provide Dementia Care in an Acute Care Hospital in Canada: A Nonrandomized Controlled Study.American journal of Alzheimer's disease and other dementias · 2016Article
- Cerebrovascular pathology and Alzheimer's disease.The Lancet. Neurology · 2016Article
- Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.International journal of clinical and experimental medicine · 2015Article
- Economic analysis of opportunities to accelerate Alzheimer's disease research and development.Annals of the New York Academy of Sciences · 2014Article
- Progress update: fluid and imaging biomarkers in Alzheimer's disease.Biological psychiatry · 2014Review
- The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014Review
- Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.Neurodegenerative disease management · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
44 authors.
Funding
Abstract
To address the pending public health crisis due to Alzheimer's disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled "State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care," on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.